What is Personalized Medicine?
Personalized medicine diagnosing, monitoring, and giving the treatment to the individual according to the segmentation of disease risks and characteristics of each patient. This approach relies on the scientific research results and how the person's molecular nature along with genetic profile makes them susceptible to the particular disease. The research on personalized medicine id increasing the ability to predict the medical treatment which can be safe and effective to people and which can not.
The market study is broken down by Type (Diagnostic, Therapeutics, Medical Care, Nutrition and Wellness), by Application (Hospitals, Molecular Diagnostic Laboratories and Testing Centers and Academic Institutes) and major geographies with country level break-up.
Quest Diagnostic (United States), Laboratory Corporation (United States), Becton, Dickinson, and Company (United States), Abbott Laboratories (United States), Pfizer Inc. (United States), Siemens Healthineers AG (Germany), CardioDx, Inc., (United States), Atrium Innovations Inc. (Canada), QIAGEN (Germany), Proteostasis Therapeutics, Inc. (United States), Asuragen (United States), Illumina, Inc. (United States) and Amgen Inc. (United States) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Personalized Medicine market by Type, Application and Region.
On the basis of geography, the market of Personalized Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospitals Pharmacies will boost the Personalized Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Patients and Consumers will boost the Personalized Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On 3rd January 2020, Atrium Innovations, a globally-recognized leader in the development, manufacturing, and commercialization of innovative, science-based nutritional health products, takes the next step in the company's mission to expand into personalized nutrition with the acquisition of San Francisco-based LivingMatrix. LivingMatrix, a technology-based, data, and algorithm-driven personalized functional medicine platform, was designed by clinicians to help practitioners effectively evaluate and engage patients, create personalized, actionable care plans, and track patient health outcomes.
On 11th December 2019, Proteostasis Therapeutics to Initiate First-Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes Ineligible for Approved CFTR Modulators. Proteostasis Therapeutics, Inc. a clinical-stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced positive, initial ex-vivo results of PTI's proprietary cystic fibrosis transmembrane conductance regulator (CFTR) modulators, PTI-801, PTI-808, and PTI-428, in individuals with CF who are ineligible for the current standard of care CFTR modulator therapies due to their genotype.
- Rising Impact on Both Clinical Research and Patient Care and Improvement in Technologies Used for Personalized Medicine
- Prevalence of Many Complicated Diseases Around the Globe
- Need for the Understanding and Monitoring the Diseases
- Growing Academic Research on Personalized Medicine
- Boosting the Adoption of Personalized Medicine
- Risks Associated with Personalized Medicine
- Low Degree of Programs About Drug Discovery in Developing Regions of the World
Key Target AudiencePersonalized Medicine Manufacturers, Personalized Medicine International traders, Personalized Medicine Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase